Inflation turns up heat on Unilever even as it backs down on M&A
LONDON (Reuters) -Unilever warned of a hit to profitability this year as it struggles to lift prices enough to offset soaring costs, sparking fresh concern among investors after a failed bid for GlaxoSmithKline's consumer health business last month.